[Multi-central randomized controlled study on electroacupuncture at Fenglong (ST 40) for regulating blood lipids]
Jie-ping Xie1, Gui-ling Liu, Jin-lin Qiao
1Acupuncture College of Beijing University of CM, Beijing 100029, China. xiejieping@sina.com
Summary
Electroacupuncture (EA) at Fenglong (ST 40) effectively regulates blood lipids, including triglycerides, cholesterol, and LDL-C, offering a safe alternative to medication with lasting effects.
Area of Science:
- Integrative and Complementary Medicine
- Cardiovascular Health
- Traditional Chinese Medicine
Context:
- Hyperlipidemia is a significant risk factor for cardiovascular diseases.
- Current pharmacological treatments for hyperlipidemia can have side effects.
- Exploring alternative therapies for lipid management is crucial.
Purpose:
- To evaluate the clinical efficacy of electroacupuncture (EA) at the Fenglong (ST 40) acupoint for managing hyperlipidemia.
- To compare the effects of EA with Xuezhikang, a traditional Chinese medicine lipid-lowering capsule.
Summary:
- A randomized trial involving 204 hyperlipidemia patients compared EA at Fenglong (ST 40) with Xuezhikang capsules.
- Both treatments showed comparable overall effective rates (83.0% vs. 85.9%).
- EA demonstrated significant triglyceride reduction and a positive trend in other lipid parameters, with no relapses observed.
Impact:
- EA at Fenglong (ST 40) presents a safe and effective non-pharmacological option for blood lipid regulation.
- The study suggests EA may serve as a viable alternative or adjunct therapy for hyperlipidemia management.
- Long-term follow-up indicates a beneficial after-effect of EA treatment on blood lipids.